Posaconazol Viatris
Posaconazol Viatris is a generic from Viatris Pharma GmbH and is listed on the FOPH Specialities List. Basic health insurance reimburses it within the authorised indication. The public price ranges from CHF 497.20 to CHF 1'939.60 depending on the pack; the co-payment is 10 per cent.
Core data
- Authorisation holder
- Viatris Pharma GmbH
- ATC code
- J02AC04
- IT group
- 08.06 Mittel gegen Pilze
- Active substances
- Posaconazolum
- Preparation type
- Generic
- On the SL since
- 01/10/2021
- Last price change
- 01/02/2026
- Co-payment
- 10%
Prices per pack
The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.
| Dosage form | Pack size | Ex-factory price | Public price | Valid from | Cat. | GTIN |
|---|---|---|---|---|---|---|
| Filmtabl 100 mg | Blist 24 Stk | CHF 442.08 | CHF 497.20 | 01/11/2023 | B | 7680681210030 |
| Filmtabl 100 mg | Blist 96 Stk | CHF 1'768.35 | CHF 1'939.60 | 01/11/2023 | B | 7680681210047 |
| Susp 40 mg/ml z Einnehm | Fl 105 ml | CHF 513.14 | CHF 574.50 | 01/11/2023 | B | 7680682710027 |
Limitation
This preparation is reimbursed only under the conditions below. The text is the binding FOPH wording; outside those conditions basic insurance does not pay.
The FOPH publishes limitation texts in German, French and Italian only. The German wording is reproduced verbatim below.
1a. Zur Prophylaxe von invasiven Mykosen (insbesondere Aspergillose) bei neutropenischen Patienten mit akuter myeloischer Leukämie oder myelodysplastischem Syndrom, die eine zytotoxische Chemotherapie erhielten.
1b. Zur Prophylaxe von invasiven Mykosen (insbesondere Aspergillose) bei Patienten mit Graft versus Host Disease (Transplantat-gegen-Empfänger-Reaktion).
2. Fusariose bei Patienten, deren Erkrankung therapieresistent ist gegenüber Amphotericin B bzw. bei Unverträglichkeit von Amphotericin B (2nd line). 3. Chromoblastomykose und Myzetom bei Patienten, deren Erkrankung therapieresistent ist gegenüber Itraconazol bzw. bei Unverträglichkeit von Itraconazol (2nd line).
4. Kokzidioidomykose bei Patienten, deren Erkrankung therapieresistent ist gegenüber Amphotericin B, Itraconazol oder Fluconazol bzw. bei Unverträglichkeit dieser Arzneimittel (2nd line).
More preparations in this group
FAQ
Is Posaconazol Viatris covered by Swiss health insurance?
Yes, but only under conditions. Posaconazol Viatris is on the Specialities List with a limitation: basic insurance reimburses it only when the conditions in the limitation text are met, in some cases only after the insurer has granted cost approval.
What does Posaconazol Viatris cost in Switzerland?
The public price is the maximum price set by the FOPH and for Posaconazol Viatris ranges from CHF 497.20 to CHF 1'939.60 per pack. The ex-factory price ranges from CHF 442.08 to CHF 1'768.35. Pharmacies may not charge more, but may charge less.
Market access
Do you need your product on the Specialities List?
Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.
- Independent directory
- Official FOPH data
- Website in eight languages